Emcure Overview

  • Year Founded
  • 1981

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 7,114


  • Latest Deal Type
  • IPO
  • (Announced)

  • Financing Rounds
  • 7

  • Investments
  • 6

Emcure General Information


Manufacturer of pharmaceutical products engaged in developing, manufacturing and marketing a broad range of biopharmaceutical products globally. The company manufactures a broad range of tablets, soft gel, hard-gel capsules and injectables to resolve blood-related, cardiology, pain and analgesics, human immunodeficiency virus (HIV), gynecology, nephrology, anti-infective, vitamins and mineral-related problems.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Private Equity-Backed
Primary Industry
Other Industries
Drug Discovery
Corporate Office
  • Plot P-II, IT-BT Park
  • M.I.D.C.,Hinjawadi
  • Pune, 411057
  • India
+91 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emcure Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Emcure‘s full profile, request access.

Request a free trial

Emcure Comparisons

HQ Location
Total Raised
Post Valuation
Manufacturer of pharmaceutical products engaged in developing, manufacturing and marketing a broad range of biopharmaceu
Pune, India
7,114 As of 2023
00000000 00.000


etur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000 000000000
Mumbai, India
00000 As of 0000
00.000 0000-00-00
00000000 0000


mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
Basel, Switzerland
00000 As of 0000
000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Emcure Competitors (90)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alkem Laboratories Formerly PE-Backed Mumbai, India 00000 0000 00000000 0000
Novartis Corporation Basel, Switzerland 00000 0000 000000000 0000
Evofem Biosciences Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
VBI Vaccines Corporation Cambridge, MA 000 000.00 000000000 000.00
Acerus Pharmaceuticals Corporation Mississauga, Canada 00 000.00 000000000 000.00
You’re viewing 5 of 90 competitors. Get the full list »

Emcure Patents

Emcure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230210793-A1 Method for rapid infusion of carmustine Pending 28-Jan-2022 000000000
US-20210038543-A1 Kit for preparing injectable carmustine solutions Pending 04-Oct-2018 0000000000
ES-2864541-T3 Improved kit for the preparation of carmustine injectable solutions Active 04-Oct-2018 0000000000
US-20200108010-A1 Kit for preparing injectable carmustine solutions Inactive 04-Oct-2018 0000000000
EP-3632411-A1 Improved kit for preparing injectable carmustine solutions Active 04-Oct-2018 A61K9/0019 0
To view Emcure’s complete patent history, request access »

Emcure Executive Team (14)

Name Title Board Seat Contact Info
Satish Mehta Founder, Chief Executive Officer, Managing Director
Vikas Thapar President, Corporate Development, Strategy & Finance
Tajuddin Shaikh Chief Financial Officer
Mukund Gurjar Ph.D Chief Scientific Officer & Executive Director
Berjis Desai Chairman & Non-Executive Director
You’re viewing 5 of 14 executive team members. Get the full list »

Emcure Board Members (14)

Name Representing Role Since
0000 0000000 Bain Capital Board Member 000 0000
000000 00000 Emcure Chairman & Non-Executive Director 000 0000
000000 0000 Parinam Law Associates Board Member 000 0000
0000000 0000000000 Emcure Chairman 000 0000
000000000 00000000 Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Emcure Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emcure Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Emcure‘s full profile, request access.

Request a free trial

Emcure Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bharadwaj Pharma 01-Jan-2016 0000000000 Pharmaceuticals
International Pharmaceutical Generics 09-Nov-2015 0000000000 Drug Discovery
Ranbaxy (Six Brands) 24-Mar-2015 0000000000 Pharmaceuticals
Sun Pharma (Tamlet) 24-Mar-2015 0000000000 Pharmaceuticals
Tillomed Laboratories 01-Apr-2014 Buyout/LBO 000.00 Pharmaceuticals
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Emcure Subsidiaries (2)

Company Name Industry Location Founded
Bharadwaj Pharma Pharmaceuticals Hamburg, Germany 2009
Tillomed Laboratories Pharmaceuticals Luton, United Kingdom 0000
To view Emcure’s complete subsidiaries history, request access »

Emcure FAQs

  • When was Emcure founded?

    Emcure was founded in 1981.

  • Who is the founder of Emcure?

    Satish Mehta is the founder of Emcure.

  • Who is the CEO of Emcure?

    Satish Mehta is the CEO of Emcure.

  • Where is Emcure headquartered?

    Emcure is headquartered in Pune, India.

  • What is the size of Emcure?

    Emcure has 7,114 total employees.

  • What industry is Emcure in?

    Emcure’s primary industry is Pharmaceuticals.

  • Is Emcure a private or public company?

    Emcure is a Private company.

  • What is Emcure’s current revenue?

    The current revenue for Emcure is 00000.

  • How much funding has Emcure raised over time?

    Emcure has raised $1.09M.

  • Who are Emcure’s investors?

    Bain Capital has invested in Emcure.

  • Who are Emcure’s competitors?

    Alkem Laboratories, Novartis, Evofem Biosciences, VBI Vaccines, and Acerus Pharmaceuticals are some of the 90 competitors of Emcure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »